MESA, AZ / ACCESS Newswire / October 3, 2025 / Medical Care Technologies Inc. (OTC PINK:MDCE) today announced it is actively exploring the integration of blockchain technology as a security framework for patient medical data in its forthcoming medical research application. Blockchain is being evaluated for its potential to ensure enhanced protection of sensitive health information, complementing the company’s commitment to full HIPAA compliance.
The app is being developed to turn users’ smart devices into personalized AI health assistants, leveraging data from photos, voice scans, facial metrics, and other non-invasive inputs to deliver diagnostic-grade wellness insights. The vision is to “turn your smart device into a personal AI doctor,” enabling more proactive, precision-driven prevention and monitoring of health conditions. Medical Care Technologies inc. The beta version of the app is scheduled for release in 2026, with initial tests focused on security protocols, database integrity, and user experience in real-world settings.
“As we build the AI framework, protecting patient privacy and ensuring data integrity are non-negotiable,” said Marshall Perkins III, CEO of Medical Care Technologies Inc. “By exploring blockchain architecture and designing for HIPAA compliance from day one, we intend to build a trusted foundation for future medical innovation.”
For additional information:
Company Website: www.medicalcaretechnologies.com
Investor Information: www.mdcestock.com
CEO Information: www.marshallperkins.com
Safe Harbor Statement:
This release contains forward-looking statements, including expected app development, HIPAA compliance, and blockchain integration. Actual results may differ due to risks and uncertainties. MDCE undertakes no duty to update these statements.
Contact:
Investor Relations
Medical Care Technologies Inc.
info@infiniteauctions.com
Website: www.mdcestock.com
SOURCE: Medical Care Technologies Inc. (OTC PINK:MDCE)
View the original press release on ACCESS Newswire
Telehealth Provider Offers FDA-Approved and Compounded Weight Loss Medications in All 50 States, Subject to…
Telehealth Platform Facilitates Compounded Semaglutide and Tirzepatide Access Through Licensed Provider Evaluation as FDA Shortage…
Analysis examines best peptides for boosting growth hormone as ReadyRx lists prescription sermorelin in injectable…
Discover the best fat burner for men in 2025. Explore Wolfson Brand’s effective fat-burning supplements…
Industry Analysis Examines How Cost, Safety, and Access Considerations Shape Semaglutide Choices as MEDVi Lists…
Deploying “Proof of Human” Infrastructure throughout Japan, a Technology Envisioned by Sam Altman and Alex…